Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
08 Jul 2026 - 10 Jul 2026

Open Tube Hematology Analyzer Is Compact and Versatile

By LabMedica International staff writers
Posted on 05 Nov 2009
An open tube analyzer enables flexible and convenient in vitro diagnostic (IVD) testing of whole blood specimens. More...


The compact hematology analyzer is ideal for situations where there are various types of sample tubes and sample types. Called Pentra ES60, it covers 26 parameters including complete blood cell (CBC) and differential (DIFF) counts. It also counts atypical lymphocytes and large immature cells and processes up to 60 samples an hour.

The Pentra ES 60's integrated multi-distribution sampling system (MDSS) enables micro-sampling (30 µL in CBC mode and 53 µL in CBC + DIFF), making the analyzer ideal for pediatric or geriatric sample types, where only small sample volumes are available.

Ideal as a standalone analyzer for small to medium sized laboratories, the Pentra ES 60 is a compact bench top system, designed to take up minimal workspace. The analyzer's Windows-based software makes it simple to use. It is adaptable to enable threshold adjustments for specific sample types. The simplicity of the analyzer's design also means there is no daily maintenance, just one automatic start up and shut down each day.

Launched by Horiba Medical (Moulton Park, UK) the Pentra ES 60 five-part differential (Diff) analyzer expands the company's open tube hematology analysis range. To ensure system security, the Pentra ES 60 can be set up with password-protected access, which also enables full audit trails for quality assurance purposes.

Horiba Medical designs and manufactures automated in vitro diagnostic systems for hematology as well as chemistry focused analytical solutions. From compact point-of-care (POC) to high throughput systems, Horiba Medical has developed an array of analyzers and data management solutions to meet many needs, enabling analysis wherever it is required.

Related Links:
Horiba Medical


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.